Mineralys Therapeutics is a publicly traded, clinical-stage biotechnology company focused on developing medicines to target diseases driven by abnormally elevated aldosterone.
Mineralys Therapeutics has 220 open roles live as of 5 September 2026. 98% of Mineralys Therapeutics's open roles are remote, placing Mineralys Therapeutics in ReqHunt Remote Index tier R3 (Anywhere), and Mineralys Therapeutics hires most in Remote (United States) (216 roles). These figures are read directly from Mineralys Therapeutics's Greenhouse careers page and were last checked on 5 September 2026.
How the ReqHunt Remote Index works — the four bands, the 10-role floor, why hybrid is excluded, and why companies with incomplete location data are withheld rather than scored low.
Read straight from Mineralys Therapeutics's careers page (greenhouse), tracked since August 2026. Refreshed every hour. “No longer listed” means the role has left the company's careers feed. That can mean filled, cancelled or withdrawn — the feed does not say which.
Data source: ReqHunt — read from Mineralys Therapeutics's Greenhouse careers page on 5 September 2026. https://reqhunt.com/company/mineralys-therapeutics
Structured data for LLMs and AI crawlers is available at /company/mineralys-therapeutics.md.
Remote roles are counted here too, by the scope they are open to. 4 of 220 live roles carry no location or remote scope we can resolve, so they are not listed below.
As of 5 September 2026, Mineralys Therapeutics ranks 2nd in the ReqHunt most remote jobs ranking with a Remote Index of R3.
Track Mineralys Therapeutics and thousands of other companies — new roles the moment they appear on the careers page.
Join free